Physiological Basis of Cardiovascular Protection by SGLT2 Inhibitors in Diabetic Ischemic Heart Disease. CDF [Internet]. 2024 Nov. 20 [cited 2026 Apr. 14];53(03):7105-13. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/4002